dipyridamole has been researched along with Cardiac Remodeling, Ventricular in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muzzarelli, S | 1 |
| Ordovas, KG | 1 |
| Cannavale, G | 1 |
| Naeger, D | 1 |
| Michaels, AD | 1 |
| Higgins, CB | 1 |
| Olivotto, I | 1 |
| Girolami, F | 1 |
| Sciagrà , R | 1 |
| Ackerman, MJ | 1 |
| Sotgia, B | 1 |
| Bos, JM | 1 |
| Nistri, S | 1 |
| Sgalambro, A | 1 |
| Grifoni, C | 1 |
| Torricelli, F | 1 |
| Camici, PG | 1 |
| Cecchi, F | 1 |
2 other studies available for dipyridamole and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Potential of delayed gadolinium enhancement magnetic resonance imaging for quantification of reverse remodeling of the peri-infarct zone in patients with ischemic cardiomyopathy treated with chronic vasodilator therapy: initial experience.
Topics: Adult; Aged; Cardiomyopathies; Contrast Media; Coronary Angiography; Coronary Circulation; Dipyridam | 2012 |
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Topics: Actin Cytoskeleton; Adolescent; Adult; Ammonia; Cardiac Myosins; Cardiomyopathy, Hypertrophic, Famil | 2011 |